US3882166A - Antimicrobial quaternary ammonium compounds - Google Patents
Antimicrobial quaternary ammonium compounds Download PDFInfo
- Publication number
- US3882166A US3882166A US242750A US24275072A US3882166A US 3882166 A US3882166 A US 3882166A US 242750 A US242750 A US 242750A US 24275072 A US24275072 A US 24275072A US 3882166 A US3882166 A US 3882166A
- Authority
- US
- United States
- Prior art keywords
- quaternary ammonium
- compounds
- bromide
- ammonium compounds
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000003856 quaternary ammonium compounds Chemical class 0.000 title abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims description 31
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 150000005840 aryl radicals Chemical class 0.000 claims description 3
- PPAXJPUUUUJRFS-UHFFFAOYSA-M dodecyl-dimethyl-[4-(4-nitrophenoxy)-4-oxobutyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 PPAXJPUUUUJRFS-UHFFFAOYSA-M 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract description 5
- 150000007860 aryl ester derivatives Chemical class 0.000 abstract description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- -1 p-nitrophenoxycarbonyl Chemical group 0.000 description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 208000002925 dental caries Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 3
- NACXKOQZXHRYPW-UHFFFAOYSA-N (4-methylphenyl) 4-chlorobutanoate Chemical compound CC1=CC=C(OC(=O)CCCCl)C=C1 NACXKOQZXHRYPW-UHFFFAOYSA-N 0.000 description 2
- WAKFRZBXTKUFIW-UHFFFAOYSA-M 2-bromo-2-phenylacetate Chemical compound [O-]C(=O)C(Br)C1=CC=CC=C1 WAKFRZBXTKUFIW-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- KRGDHDFRUNXAPO-UHFFFAOYSA-M dimethyl-(2-oxo-2-phenoxyethyl)-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CC(=O)OC1=CC=CC=C1 KRGDHDFRUNXAPO-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000005528 methosulfate group Chemical group 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- SFBHPFQSSDCYSL-UHFFFAOYSA-N n,n-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCCCN(C)C SFBHPFQSSDCYSL-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 206010044029 Tooth deposit Diseases 0.000 description 1
- SREXBZXCTVBZIH-UHFFFAOYSA-M [I-].CCCCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=C(Cl)C=C(Cl)C=C1Cl Chemical compound [I-].CCCCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=C(Cl)C=C(Cl)C=C1Cl SREXBZXCTVBZIH-UHFFFAOYSA-M 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZVIBWXFCYNDUEG-UHFFFAOYSA-M dimethyl-(2-naphthalen-2-yloxy-2-oxoethyl)-tetradecylazanium;bromide Chemical compound [Br-].C1=CC=CC2=CC(OC(=O)C[N+](C)(C)CCCCCCCCCCCCCC)=CC=C21 ZVIBWXFCYNDUEG-UHFFFAOYSA-M 0.000 description 1
- JRABJWCPYFBQPQ-UHFFFAOYSA-M dimethyl-(4-oxo-4-phenoxybutyl)-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=CC=CC=C1 JRABJWCPYFBQPQ-UHFFFAOYSA-M 0.000 description 1
- ABTYZKIAIYDQBX-UHFFFAOYSA-M dimethyl-[2-(4-nitrophenoxy)-2-oxoethyl]-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ABTYZKIAIYDQBX-UHFFFAOYSA-M 0.000 description 1
- ALGVJITYAQGEPA-UHFFFAOYSA-M dimethyl-[4-oxo-4-(2,4,6-trichlorophenoxy)butyl]-tetradecylazanium bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=C(Cl)C=C(Cl)C=C1Cl ALGVJITYAQGEPA-UHFFFAOYSA-M 0.000 description 1
- JATGOTROSARUQG-UHFFFAOYSA-M dimethyl-propyl-tetradecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)CCC JATGOTROSARUQG-UHFFFAOYSA-M 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- AKIXRIRXUUBRBQ-UHFFFAOYSA-M dodecyl-dimethyl-(2-oxo-2-phenoxyethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC(=O)OC1=CC=CC=C1 AKIXRIRXUUBRBQ-UHFFFAOYSA-M 0.000 description 1
- BYXXUIUKWIGONA-UHFFFAOYSA-M dodecyl-dimethyl-(4-oxo-4-phenoxybutyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=CC=CC=C1 BYXXUIUKWIGONA-UHFFFAOYSA-M 0.000 description 1
- BEWAGUPTRAVQPJ-UHFFFAOYSA-M dodecyl-dimethyl-[4-oxo-4-(2,4,6-trichlorophenoxy)butyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCCC(=O)OC1=C(Cl)C=C(Cl)C=C1Cl BEWAGUPTRAVQPJ-UHFFFAOYSA-M 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- DZFYOYRNBGNPJW-UHFFFAOYSA-N ethoxythallium Chemical compound [Tl+].CC[O-] DZFYOYRNBGNPJW-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 150000003948 formamides Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- FHUXABWUPXDLRL-UHFFFAOYSA-N hexadecyl-[5-(4-nitrophenoxy)-5-oxopentyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH2+]CCCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 FHUXABWUPXDLRL-UHFFFAOYSA-N 0.000 description 1
- WHWDWIHXSPCOKZ-UHFFFAOYSA-N hexahydrofarnesyl acetone Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)=O WHWDWIHXSPCOKZ-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- PGAPATLGJSQQBU-UHFFFAOYSA-M thallium(i) bromide Chemical compound [Tl]Br PGAPATLGJSQQBU-UHFFFAOYSA-M 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- R is a long chain alkyl group of 12-18 carbon atoms, R and R are methyl or ethyl groups, n is an integer from 1 to 6
- Ar is an aryl radical comprising a phenyl, naphthyl or substituted phenyl or naphthyl wherein said substituents include alkyl, alkoxy, acetamido, amido, phenyl, naphthyl, haloand/or nitroradicals
- X is a compatible anion.
- quaternary ammonium compounds include:
- halides such as the fluorides, the sulfates and methosulfates, and analogous compounds, may also be employed herein as effective antibactericides.
- test tube serial dilution test in which an appropriate number of test tubes of broth containing decreasing concentrations of the test agent was innoculated with the test organism.
- the test agent was initially at a 10% concentration in ethanol which was progressively diluted, first tenfold, and then twofold, each time with broth.
- the broth employed contained 17 gm of trypticase peptone, 3 gm of phytone peptone, 5 gm of sodium chloride, 2.5 gm of dipotassium phosphate, 2.5 gm of dextrose and water to 1 liter. After a suitable period of incubation, the tubes were examined for the presence or absence of growth.
- the activity of the test agent was the lowest concentration which inhibited the growth of the organism and is expressed as the minimal inhibitory concentration in ug/ml.
- compounds of the instant invention When used against bacteria, compounds of the instant invention may be applied directly to the surface to be protected or may be dissolved in a pharmaceutical carrier.
- a pharmaceutical carrier typically, an effective amount, e.g., 0.1 to about 10% by weight of the compound, is included in an inert carrier and a dispersing or surface-active agent.
- an effective amount, e.g., 0.1 to about 10% by weight may be incorporated into a solid carrier which may be inert, such as talc, clay, diatomaceous earth, flour, etc.
- the quaternary ammonium aryl esters of instant invention are particularly effective in inhibiting the development of dental calculus as shown by the results of tests on litter-mated albino rats, in groups of 15 males and 15 females, who were fed a Zipkin-McClure calculus producing diet. For 6 weeks, the teeth of each animal were swabbed for 30 seconds each day with a 0.1% concentration test solution or water for the control group. The animals were then sacrificed, defleshed, and scored by Baers method for calculus. The results were analyzed by Students 1" test and in the results quoted were 99% significant.
- plaque-reactive compounds have a quaternary ammonium group to provide a temporary binding to the organic constituents of plaque and a reactive site for permanent attachment, whereby the compound is held until the reactive group, namely the aryl ester, has formed a more permanent bond with some atom or group in the protein or carbohydrate of the plaque.
- Instant quaternary compounds are also effective in reducing caries, as shown by the results of tests on litter-mated caries-susceptible hamsters, in groups of 15 males and 15 females, who were fed a Mitchell cariogenic diet and received constant deionized water. For 6 weeks, the teeth of each animal were swabbed for 30 seconds each day with a 0.1% concentration test solution or water for the control group. The animals were then sacrificed, defleshed, and scored by a modified version of the Keyes scoring method. Mean averages and percentage changes from the control were determined and tested statistically to determine the significance.
- the oral preparation is a dentifrice, such as a dental cream, tablet or powder, containing as a vehicle about 20-95% by weight of a waterinsoluble polishing material, preferably including water-insoluble phosphate such as dicalcium phosphate, tricalcium phosphate, trimagnesium phosphate.
- the dentifrice may also include water; binders such as glycerine, sorbitol, propylene glycol, and polyethylene glycol 400; detergents; gelling agents such as Irish moss and sodium carboxymethyl cellulose; additional antibacterial agents; coloring or whitening agents; preservatives; silicones; chlorophyl compounds; additional ammoniated materials; flavoring or sweetening materials; and compounds which provide fluorine-containing ion such as sodium fluoride, stannous fluoride and sodium monofluorophosphate.
- binders such as glycerine, sorbitol, propylene glycol, and polyethylene glycol 400
- detergents such as Irish moss and sodium carboxymethyl cellulose
- additional antibacterial agents such as Irish moss and sodium carboxymethyl cellulose
- coloring or whitening agents coloring or whitening agents
- preservatives silicones
- chlorophyl compounds additional ammoniated materials
- flavoring or sweetening materials and compounds which provide fluorine-containing ion such
- the oral preparation may also be a liquid such as mouth rinse, which typically contains 2099% by weight of an aqueous alcohol such as ethanol, mpropyl, or isopropyl alcohol and being present in amount of about 530% by weight of the oral preparation.
- aqueous alcohol such as ethanol, mpropyl, or isopropyl alcohol
- Such oral preparations are typically applied by brushing the teeth or rinsing the oral cavity for 30-90 seconds at least once daily.
- Typical oral preparations of the invention which can be applied in this manner are set forth below.
- any of the listed 17 quaternary compounds and analagous compounds may be incorporated into above or similar dentifrice or mouth rinse formulations to provide protection against plaque formation, calculus and/or caries.
- Instant quaternary ammonium arylesters can be prepared by a two-step process of reacting essentially equimolar quantities of a phenol or naphthol with a haloalkanoic acid, or salt of a phenol or naphthol with a halo-alkanoyl halide to form an aryl halo-alkanoate; followed by reacting with essentially an equimolar amount of a tertiary amine to form the quaternary ammonium salt, as illustrated by the following equations:
- phenolic salts may be used in lieu of thallous phenolate, inclusive of the alkali metal phenolic salts, etc. as the reactant with a halo-alkanoyl halide in accordance with Equation 3.
- the preferred process utilizes the phenol or naphthol reactant as illustrated by Equation l.
- R is a long chain alkyl group of 12-18 carbon atoms, R and R are methyl or ethyl groups; n is an integer from 1-6; Ar is a substituted aryl radical selected from the group consisting of phenyl and naphthyl, said substituted moiety being selected from the group consisting of tri-haloand mono-nitro-radicals; and X is an anion selected from the class consisting of halides, sulfates and methosulfates.
- Ar is a tri-chloro-substituted aryl radical wherein said aryl radical is selected from the group 6. 3-( p-nitrophenoxycarbonyl )-propyldimethyldodecylammonium bromide.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Novel quaternary ammonium compounds which include an aryl ester linked to the quaternary ammonium group by a hydrocarbon chain.
Description
United States Patent [1 1 Bauman ANTIMICROBIAL QUATERNARY AMMONIUM COMPOUNDS [75] Inventor: Robert Andrew Bauman, New
Brunswick, NJ.
[73] Assignee: Colgate-Palmolive Company, New
York, NY.
221 Filed: Apr. 10, 1972 211 Appl. No.: 242,750
[52] US. Cl 260/479 S; 424/3 ll [51] Int. Cl. C07c 101/42 [58] Field of Search 260/479 S [56] References Cited UNITED STATES PATENTS 2,087,565 7/1937 Balle et al 260/482 2,367,878 l/l945 Lee 260/482 FOREIGN PATENTS OR APPLICATIONS l, l 24,508 3/1962 Germany OTHER PUBLICATIONS Janata II, Chem. Abstracts, Vol. 65, (1966), p. l2l0l.
Capek et al., Chem. Abstracts, Vol. 72 (1970), Abstr. No. l08238j.
Chem. Abstracts, Subj. Index (l972-Pt.l p. 2525.
Vandenberghe, Chem. Abstracts, Vol. 72 (I970), Abstr. No. 78705q.
Primary Examiner.lames A. Patten Attorney, Agent, or Firm-Robert L. Stone; Murray M. Grill; Herbert S. Sylvester 5 7 ABSTRACT Novel quaternary ammonium compounds which include an aryl ester linked to the quaternary ammonium group by a hydrocarbon chain.
6 Claims, No Drawings ANTIMICROBIAL QUATERNARY AMMONIUM COMPOUNDS The present invention relates to novel quaternary ammonium compounds represented by the general formula:
wherein R is a long chain alkyl group of 12-18 carbon atoms, R and R are methyl or ethyl groups, n is an integer from 1 to 6, Ar is an aryl radical comprising a phenyl, naphthyl or substituted phenyl or naphthyl wherein said substituents include alkyl, alkoxy, acetamido, amido, phenyl, naphthyl, haloand/or nitroradicals, and X is a compatible anion. These quaternary compounds possess superior anti-microbial, anti-caries, and anti-calculus activity, are mild and substantially non-toxic.
Typical examples of the quaternary ammonium compounds embraced by this invention include:
1 3-( p-cresoxycarbonyl) propyldimethyltetradecylammonium bromide 2. phenoxycarbonylmethyldimethyltetradecylammonium bromide 3. 3-( phenoxycarbonyl)propyldimethyltetradecylammonium bromide 4. 3-(phenoxycarbonyl)propyldimethyldodecylammonium bromide 5. phenoxycarbonylmethyldimethyldodecylammonium bromide 6. p-nitrophenoxycarbonylmethyldimethyltetradecylammonium bromide 7. 3-( pnitrophenoxycarbonyl )propyldimethyldodecylammonium bromide 8. 3 p-nitrophenoxycarbonyl )propyldimethyltetradecylammonium bromide 9. 3-( 2 ',4',6' trichlorophenoxycarbonyl)propyldimethyldodecylammonium bromide.
10. 3-(2' ,4 ,6 trichlorophenoxycarbonyl)propyldimethyltetradecyl ammonium bromide.
l l. 3-(p-cresoxycarbonyl)propyltetradecyldimethyl ammonium chloride.
12. 3-(2,4',6' trichlorophenoxycarbonyl)propyldim ethyltetradecyl ammonium iodide.
13. S-(p-cresoxycarbonyl)pentyldimethylhexadecyl ammonium chloride 14. 6-(phenoxycarbonyl)hexyldiethylocatadecyl ammonium bromide 15. 4-(p-nitrophenoxycarbonyl)butylhexadecyl ammonium bromide 16. 2-naphthyloxycarbonylmethyldimethyltetradecyl ammonium bromide 17. l-naphthyloxy carbonylmethyldimethyldodecyl ammonium bromide.
The halides, such as the fluorides, the sulfates and methosulfates, and analogous compounds, may also be employed herein as effective antibactericides.
[t has been observed that the compounds generally described by the foregoing formula are particularly effective against gram positive organisms such as Staphylococcus aureus, Streptococcus mitis, Bacillus subtilis and Corynebacterium acnes.
The anti-microbial nature of the instant novel compounds was shown by a standard test tube serial dilution test in which an appropriate number of test tubes of broth containing decreasing concentrations of the test agent was innoculated with the test organism. The test agent was initially at a 10% concentration in ethanol which was progressively diluted, first tenfold, and then twofold, each time with broth. The broth employed contained 17 gm of trypticase peptone, 3 gm of phytone peptone, 5 gm of sodium chloride, 2.5 gm of dipotassium phosphate, 2.5 gm of dextrose and water to 1 liter. After a suitable period of incubation, the tubes were examined for the presence or absence of growth. The activity of the test agent was the lowest concentration which inhibited the growth of the organism and is expressed as the minimal inhibitory concentration in ug/ml.
These dilution tests evidence the bacteriostatic effectiveness of compounds of this invention against gram positive bacteria.
When used against bacteria, compounds of the instant invention may be applied directly to the surface to be protected or may be dissolved in a pharmaceutical carrier. Typically, an effective amount, e.g., 0.1 to about 10% by weight of the compound, is included in an inert carrier and a dispersing or surface-active agent. Alternatively, an effective amount, e.g., 0.1 to about 10% by weight, may be incorporated into a solid carrier which may be inert, such as talc, clay, diatomaceous earth, flour, etc.
The quaternary ammonium aryl esters of instant invention are particularly effective in inhibiting the development of dental calculus as shown by the results of tests on litter-mated albino rats, in groups of 15 males and 15 females, who were fed a Zipkin-McClure calculus producing diet. For 6 weeks, the teeth of each animal were swabbed for 30 seconds each day with a 0.1% concentration test solution or water for the control group. The animals were then sacrificed, defleshed, and scored by Baers method for calculus. The results were analyzed by Students 1" test and in the results quoted were 99% significant.
TABLE ll Compound No. Calculus Reduction The results set forth above indicate the significant effectiveness of the quaternary compounds of the invention in inhibiting formation of oral calculus in concentrations as low as 0.1%.
A theoretical explanation for this effectiveness resides in the possible reactivity of the aryl esters with the amino or other group in the protein molecule of plaque to chemically modify plaque and inhibit calculus. The presence of the quaternary ammonium group in aforesaid esters provides substantivity before reaction occurs. More specifically, plaque-reactive compounds have a quaternary ammonium group to provide a temporary binding to the organic constituents of plaque and a reactive site for permanent attachment, whereby the compound is held until the reactive group, namely the aryl ester, has formed a more permanent bond with some atom or group in the protein or carbohydrate of the plaque. Laboratory tests have shown that instant quaternary esters react rapidly with amine groups (i.e., in protein) to form amides, the rate of reaction, however, varying with the particular ester utilized. In addition to the protein breakdown via the amide bond, the quaternary ammonium group may increase the solubility of the plaque, thereby rendering the plaque more dispersible and consequently easily removable from the teeth.
Instant quaternary compounds are also effective in reducing caries, as shown by the results of tests on litter-mated caries-susceptible hamsters, in groups of 15 males and 15 females, who were fed a Mitchell cariogenic diet and received constant deionized water. For 6 weeks, the teeth of each animal were swabbed for 30 seconds each day with a 0.1% concentration test solution or water for the control group. The animals were then sacrificed, defleshed, and scored by a modified version of the Keyes scoring method. Mean averages and percentage changes from the control were determined and tested statistically to determine the significance.
These results are indicative of the significant effectiveness of instant quaternary compounds in the reduction of caries in concentrations as low as 0.1%.
When compounds of the instant invention are intended for use in compositions which reduce formation of caries and inhibit formation of oral calculus, they are typically incorporated in oral preparation in effective amounts up to about by weight, preferably 0. l-l%, and most preferably 0.250.5% by weight of the oral preparation. Typically, the oral preparation is a dentifrice, such as a dental cream, tablet or powder, containing as a vehicle about 20-95% by weight of a waterinsoluble polishing material, preferably including water-insoluble phosphate such as dicalcium phosphate, tricalcium phosphate, trimagnesium phosphate. The dentifrice may also include water; binders such as glycerine, sorbitol, propylene glycol, and polyethylene glycol 400; detergents; gelling agents such as Irish moss and sodium carboxymethyl cellulose; additional antibacterial agents; coloring or whitening agents; preservatives; silicones; chlorophyl compounds; additional ammoniated materials; flavoring or sweetening materials; and compounds which provide fluorine-containing ion such as sodium fluoride, stannous fluoride and sodium monofluorophosphate.
The oral preparation may also be a liquid such as mouth rinse, which typically contains 2099% by weight of an aqueous alcohol such as ethanol, mpropyl, or isopropyl alcohol and being present in amount of about 530% by weight of the oral preparation.
Such oral preparations are typically applied by brushing the teeth or rinsing the oral cavity for 30-90 seconds at least once daily. Typical oral preparations of the invention which can be applied in this manner are set forth below.
EXAMPLE l Dental Cream 3-( p-cresoxycarbonyl )propyldimethyltetradecylammonium bromide 0.50 Nonionic detergent L00 Glycerine 22.00 Sodium pyrophosphate 0.25 Carboxymethyl cellulose 0.85 Sodium saccharin 0.20 Sodium benzoate 050 Calcium carbonate (precipitated) 5.00 Dicalcium phosphate dihydrate 46.75 Flavor 0.80 Water 22.15
'Tween Polyoxyethylene (20 moles ethylene oxide) sorbitan monooleate.
EXAMPLE 2 Mouthwash Compound No. l 0.25 Nonionic detergent (Pluronic F-63) I00 Ethyl alcohol (containing flavor) 15.00 Glycerine I000 Saccharin 0.02 Water 73.73
' Block polymer of 80% polyoxyethylene and 20% polyoxypropylene.
In lieu of Compound No. 1, any of the listed 17 quaternary compounds and analagous compounds may be incorporated into above or similar dentifrice or mouth rinse formulations to provide protection against plaque formation, calculus and/or caries.
Instant quaternary ammonium arylesters can be prepared by a two-step process of reacting essentially equimolar quantities of a phenol or naphthol with a haloalkanoic acid, or salt of a phenol or naphthol with a halo-alkanoyl halide to form an aryl halo-alkanoate; followed by reacting with essentially an equimolar amount of a tertiary amine to form the quaternary ammonium salt, as illustrated by the following equations:
[ ca OCO(CH2)3N(CH3)2C1 11 COOH 5 3. CHEQO T]. Cl(CH COCl 1 01-1 0c (CH2) 01 T101 The phenol salt may be obtained by the reaction illustrated by the following equation:
Other phenolic salts may be used in lieu of thallous phenolate, inclusive of the alkali metal phenolic salts, etc. as the reactant with a halo-alkanoyl halide in accordance with Equation 3. The preferred process utilizes the phenol or naphthol reactant as illustrated by Equation l.
The following examples illustrate the manner in which compounds of this invention are prepared.
EXAMPLE 3 Preparation of phenoxycarbonylmethyltetradecyldimethyl ammonium bromide:
Compound 2. OOOCH N( 1 To a solution of 37.6 g (0.40 mol) phenol in 600 ml of ether was added with stirring l00 g (0.40 mol) of thallous ethoxide. The white precipitate of 120 g thallous phenoxide was removed by filtration and dried in vacuum. To a solution of 80.9 g (0.40 mol) bromoacetyl bromide in 1 liter of ether was added portionwise with stirring 120 g (0.40 mol) of thallous phenoxide. After standing overnight, the reaction mixture was filtered from thallous bromide, washed with water until neutral, and then dried over Drierite. After removal of the ether, the phenyl bromoacetate was distilled through a short Vigreux column and product was collected from 80-86 (1.3 T).
A mixture of 55 g (0.26 mol) phenyl bromoacetate and 62 g (0.26 mol) of tetradecyldimethylamine was allowed to stand at room temperature for 3 days. The resultant crystalline mass was washed well with ether and dried to 114 g. Recrystallized from ethyl acetate and vacuum dried, the compound melted at 879l.5.
Analysis: Calculated for C H BrNO,: C, 63.14; H, 9.27; Br, V7.50. Found: C, 62.88; H, 9.l4; Br, 17.6l.
EXAMPLE 4 Other compounds prepared in accordance with the procedure of Example 3 include:
EXAMPLE 5 Preparation of 3-(p-cresoxycarbonyl)propyltetradecyldimethyl ammonium chloride:
C ompound CH 5 the acid with 6 g of sodium bicarbonate, the reaction mixture was filtered, and the solvent removed by vacuum evaporation. The residue was distilled through a inch Vigreux column to yield l06 g of colorless oil boiling at 144 (4T), and confirmed by infrared and nmr spectra as p-cresyl 4-chlorobutyrate.
A mixture of 89.5 g (0.42 mol) p-cresyl 4- chlorobutyrate and 102.0 g (0.42 mol) tetradecyldimethylamine was prepared in a 500 ml Erlenmeyer flask, stoppered and placed in an oven at l00 for 3 days.
After cooling to room temperature, the crystalline mass was slurried with ether, filtered, and dried to 145 g. The product was recrystallized from ethyl acetate; mp. l l01 14 to a liquid crystal, 166-167 to a clear liquid.
Analysis: Calculated for CZTHMCINOQ: C, 71.41; H, l0.65',Cl,7,81. Found: C. 71.43, H, 10.78; Cl, 7.83.
Although this invention has been described with reference to specific examples, it will be apparent to one 40 skilled in the art that various modifications may be made thereto which fall within its scope.
What is claimed:
1. A chemical compound having the structural for mula:
l 2 II 5 R N(CH COAr X 14.1. Calcd. Found wherein R is a long chain alkyl group of 12-18 carbon atoms, R and R are methyl or ethyl groups; n is an integer from 1-6; Ar is a substituted aryl radical selected from the group consisting of phenyl and naphthyl, said substituted moiety being selected from the group consisting of tri-haloand mono-nitro-radicals; and X is an anion selected from the class consisting of halides, sulfates and methosulfates.
2. A chemical compound as set forth in claim 1, wherein n is 3.
3. A chemical compound as set forth in claim 2 wherein Ar is a tri-chloro-substituted aryl radical wherein said aryl radical is selected from the group 6. 3-( p-nitrophenoxycarbonyl )-propyldimethyldodecylammonium bromide.
Claims (6)
1. A CHEMICAL COMPOUND HAVING THE STRUCTURAL FORMULA:
2. A chemical compound as set forth in claim 1, wherein n is 3.
3. A chemical compound as set forth in claim 2 wherein Ar is a tri-chloro-substituted aryl radical wherein said aryl radical is selected from the group consisting of phenyl and naphthyl.
4. A chemical compound as set forth in claim 1, wherein X is a halide.
5. A chemical compound as set forth in claim 1, having the structural formula:
6. 3-(p-nitrophenoxycarbonyl)-propyldimethyldodecylammonium bromide.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242750A US3882166A (en) | 1972-04-10 | 1972-04-10 | Antimicrobial quaternary ammonium compounds |
| US453359A US3928618A (en) | 1972-04-10 | 1974-03-21 | Oral compositions |
| US05/551,372 US3953605A (en) | 1972-04-10 | 1975-02-20 | Antimicrobial quaternary ammonium compounds compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242750A US3882166A (en) | 1972-04-10 | 1972-04-10 | Antimicrobial quaternary ammonium compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US05/551,372 Division US3953605A (en) | 1972-04-10 | 1975-02-20 | Antimicrobial quaternary ammonium compounds compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3882166A true US3882166A (en) | 1975-05-06 |
Family
ID=22916033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US242750A Expired - Lifetime US3882166A (en) | 1972-04-10 | 1972-04-10 | Antimicrobial quaternary ammonium compounds |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3882166A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4127671A (en) * | 1976-04-22 | 1978-11-28 | Societe Anonyme Dite: Hexachime | P-acetamidophenyl diethylaminoacetate |
| US5059344A (en) * | 1987-03-23 | 1991-10-22 | Kao Corporation | Bleaching composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2087565A (en) * | 1931-06-24 | 1937-07-20 | Gen Aniline Works Inc | Quaternary ammonium compounds and a process of preparing them |
| US2367878A (en) * | 1939-05-04 | 1945-01-23 | Hoffmann La Roche | Betaine esters |
-
1972
- 1972-04-10 US US242750A patent/US3882166A/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2087565A (en) * | 1931-06-24 | 1937-07-20 | Gen Aniline Works Inc | Quaternary ammonium compounds and a process of preparing them |
| US2367878A (en) * | 1939-05-04 | 1945-01-23 | Hoffmann La Roche | Betaine esters |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4127671A (en) * | 1976-04-22 | 1978-11-28 | Societe Anonyme Dite: Hexachime | P-acetamidophenyl diethylaminoacetate |
| US5059344A (en) * | 1987-03-23 | 1991-10-22 | Kao Corporation | Bleaching composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0038192B1 (en) | 5-alkylsalicylanilides derivatives and method for inhibiting the growth of microorganisms | |
| CA1154769A (en) | Morpholino compounds | |
| US4894221A (en) | Method of treating plaque using morpholine compounds | |
| EP0038191B1 (en) | 5-acylsalicylanilides derivatives and method for inhibiting the growth of microorganisms | |
| US4820507A (en) | Oral and dental hygiene preparations | |
| US3956479A (en) | Pharmaceutical composition containing novel quaternary ammonium compounds | |
| US3277118A (en) | Quaternary ammonium fluorides | |
| US3953605A (en) | Antimicrobial quaternary ammonium compounds compositions | |
| US3928618A (en) | Oral compositions | |
| CA1198738A (en) | Oral compositions comprising n.sup.g-acyl derivatives of arginine | |
| US4119711A (en) | Piperidino derivatives | |
| US3882166A (en) | Antimicrobial quaternary ammonium compounds | |
| EP0198366B1 (en) | Novel 5-alkylsulfonylsalicylanlides and microbiocidal compositions for controlling the growth of microorganisms | |
| EP0255807A2 (en) | N-alkylamides of d-(+) -carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same | |
| US4046873A (en) | Alicyclic amido-quaternary ammonium anti-bacterial agents | |
| US3928411A (en) | New quaternary compounds having anti-microbial activity | |
| EP0174632B1 (en) | Anti-microbial n-(1-(alkyl or arylmethyl)-4(1h)-pyridinylidine)alkanamines and acid addition salts thereof and process for preparation, methods of use and compositions thereof | |
| US4082756A (en) | Quaternary quinuclidinium carbamates and thiocarbamates | |
| US3621048A (en) | Quaternary ammonium compounds | |
| US4007281A (en) | Pharmaceutical compositions containing quaternary ammonium compounds | |
| US4059687A (en) | Ester substituted dibiguanides and non-toxic antimicrobial compositions thereof | |
| US3992431A (en) | Quaternary compounds having anti-microbial activity | |
| US3898284A (en) | Ether-linked quaternary ammonium compounds | |
| US4038303A (en) | Quaternary ammonium carbamide compounds | |
| US4102994A (en) | Aliphatic amido-quaternary ammonium anti-microbial compounds |